Wuhan Raycus Fiber Laser Technologies Co Ltd Class A (300747.SZ) stock: key figures, P/E, revenue and dividend
Information Technology · Electronic Equipment & Instruments · China · ISIN CNE100003654
Wuhan Raycus Fiber Laser Technologies Co Ltd Class A financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 3.20 bn CNY | 3.47 bn CNY |
| Gross profit | 578.86 m CNY | 3.47 bn CNY |
| Operating income | 120.48 m CNY | 153.82 m CNY |
| EBIT | 4.17 m CNY | 153.82 m CNY |
| Net income | 134.27 m CNY | 166.39 m CNY |
| Diluted EPS – continuing operations | 0.24 CNY | 0.30 CNY |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Wuhan Raycus Fiber Laser Technologies Co Ltd Class A
Wuhan Raycus Fiber Laser Technologies Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and repair services of fiber lasers in China and internationally. It offers continuous, quasi-continuous, pulsed, and narrow linewidth fiber lasers, as well as direct semiconductor, ultra-fast, industrial, consumer, security, and medical lasers. The company is also involved in fiber optic manufacturing; software development; and housing rental. It exports its products. The company was founded in 2007 and is based in Wuhan, China.
More stocks
- Shanxi Coal International Energy Group Co Ltd (600546.SS)
- Valeo SE (FR.PA)
- GEO GROUP INC (GEO)
- Henzhen Zhaowei Machinery And Elect (003021.SZ)
- Beijing Sifang Automation Co Ltd (601126.SS)
- Dosilicon Co Ltd (688110.SS)
- Russel Metals Inc. (RUS.TO)
- Xenon Pharmaceuticals Inc. (XENE)
- Ardentec (3264.TWO)
- Shanghai Zhonggu Logistics Co Ltd (603565.SS)
- Covivio Hotels SCA (COVH.PA)
- Ottobock SE & Co KgaA (OBCK.DE)
Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.